Quick Answer
ADIAL PHARMACEUTICALS, INC. reported Common Stock Shares Outstanding of 1.11 million shares for the year ending 2025.
- ADIAL PHARMACEUTICALS, INC. showed an increase of +329.2% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from ADIAL PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2018: 3.56 million shares | Q3 2018: 6.56 million shares | Q1 2019: 10.17 million shares | Q2 2019: 10.24 million shares | Q3 2019: 10.29 million shares | Q1 2020: 10.63 million shares | Q2 2020: 13.45 million shares | Q3 2020: 14.22 million shares | Q1 2021: 17.27 million shares | Q2 2021: 18.41 million shares | Q3 2021: 20.45 million shares | Q1 2022: 23.72 million shares | Q2 2022: 25.85 million shares | Q3 2022: 26.85 million shares | Q1 2023: 28.52 million shares | Q2 2023: 1.20 million shares | Q3 2023: 1.22 million shares | Q1 2024: 4.05 million shares | Q2 2024: 4.29 million shares | Q3 2024: 6.41 million shares | Q1 2025: 6.65 million shares | Q2 2025: 21.53 million shares | Q3 2025: 23.84 million shares.
- Over the full 9 years of available data (2017 to 2025), ADIAL PHARMACEUTICALS, INC.'s Common Stock Shares Outstanding has declined by 66.0%.
- Historical annual values: Fiscal year 2025: 1.11 million shares | Fiscal year 2024: 258,826 shares | Fiscal year 2023: 1.66 million shares | Fiscal year 2022: 1.07 million shares | Fiscal year 2021: 20.95 million shares | Fiscal year 2020: 14.39 million shares | Fiscal year 2019: 10.37 million shares | Fiscal year 2018: 6.86 million shares | Fiscal year 2017: 3.27 million shares.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: